Several other investigators have also reported that the PIK3CA mutated compared with wild-type genotype is associated with a better prognosis, though a robust prognostic study is yet to be performed in large clinical breast cancer cohorts [7], [8], [9], [10]. The gene discussed is PIK3CA; the disease is breast carcinoma.